Abstract
Cerebral palsy (CP) is a neuromuscular condition caused by deficits in the developmental trajectory of the brain or due to physical injury to the developing brain. It affects many school-going and newly born children and is indicated by exaggerated movements and reflexes and unusual movements of the limbs, digits and posture. The present review article discusses the therapeutic potential of botulinum toxin (BoNT) for the treatment of CP. BoNT is a well-known commercially available neurotoxin which blocks the release of neurotransmitters (e.g. acetylcholine), thereby decreasing the undesirable muscle movement of the voluntary muscles in the case of CP. The review also discusses the effectiveness of the therapy, rehabilitation of the patients after treatment and various scales used to measure the movement before and after therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
